Sterling Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Sterling Capital Management’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.38K	Sell	1,042 -804	-44%	-$5.25K	﹤0.01%	2483
2026 Q1	$12.8K	Sell	1,846 -1,365	-43%	-$10.5K	﹤0.01%	2250
2025 Q4	$28.3K	Sell	3,211 -633	-16%	-$3.48K	﹤0.01%	2044
2025 Q3	$19.2K	Buy	3,844 +2,316	+152%	+$10.7K	﹤0.01%	2168
2025 Q2	$7.21K	Buy	1,528 +544	+55%	+$2.38K	﹤0.01%	2317
2025 Q1	$4.52K	Sell	984 -843	-46%	-$3.93K	﹤0.01%	2218
2024 Q4	$8.75K	Buy	1,827 +1,646	+909%	+$7.9K	﹤0.01%	2228
2024 Q3	$849	Buy	+181	New	+$970	﹤0.01%	2624
2014 Q2	–	Sell	-10,589	Closed	-$172K	–	939
2014 Q1	$172K	Buy	+10,589	New	+$151K	﹤0.01%	915

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sterling Capital Management's VNDA Position: Q2 2026 in Review

Sterling Capital Management reduced its Vanda Pharmaceuticals (VNDA) stake by 44% in Q2 2026, selling an estimated $5.25K and leaving 1,042 shares worth $6.38K. The position accounts for ﹤0.01% of the portfolio, ranked #2483.

Sterling Capital Management first reported a position in VNDA in Q1 2014 and has held it in 9 quarters since. The position peaked at $172K in Q1 2014. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

Sterling Capital Management held 1,042 shares of Vanda Pharmaceuticals worth $6.38K as of Q2 2026.
Sterling Capital Management sold 804 Vanda Pharmaceuticals shares in Q2 2026, an estimated $5.25K.
Vanda Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2483 holding.
Sterling Capital Management first reported a position in Vanda Pharmaceuticals in Q1 2014 and has held it in 9 quarters since.
Sterling Capital Management's Vanda Pharmaceuticals position peaked at $172K in Q1 2014.
172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.